Drug intelligence / Profile preview

fufang changtai granules

Development stage
Unknown
Lead developer
Naval Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

Fufang Changtai Granules is a Traditional Chinese Medicine (TCM) compound developed by the Second Military Medical University (SMMU), specifically within the Department of Gastroenterology at Changhai Hospital. It is primarily indicated for the treatment of ulcerative colitis (UC), particularly for patients presenting with damp-heat and spleen deficiency patterns. The formulation is a complex mixture of herbal extracts, typically including *Astragalus membranaceus* (Huangqi), *Coptis chinensis* (Huanglian), *Sanguisorba officinalis* (Diyu), *Curcuma wenyujin* (Yujin), and *Paeonia lactiflora* (Baishao). Its mechanism of action involves the suppression of intestinal inflammation through the inhibition of the NF-κB signaling pathway and the subsequent downregulation of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Clinical studies conducted in China have demonstrated its efficacy in inducing clinical remission and promoting mucosal healing in patients with mild-to-moderate ulcerative colitis.

Brand names
Changtai Granules
Other names
Compound Changtai GranulesChangtai Keli
02

Targets

XO (Xanthine Oxidoreductase)

Beyond the preview

Go deeper on fufang changtai granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fufang changtai granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call